Park Place Capital Corp »

Agios Pharmaceuticals shares owned by Park Place Capital Corp

Quarter-by-quarter ownership of Agios Pharmaceuticals (AGIO) shares owned by Park Place Capital Corp from 13F filings

Historical chart of Park Place Capital Corp investment in Agios Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Agios Pharmaceuticals held by Park Place Capital Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Agios Pharmaceuticals by Park Place Capital Corp

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.2k 72 44.43
2024-06-30 $3.1k 72 43.13
2024-03-31 $2.1k 72 29.24

More positions owned by Park Place Capital Corp

Aptus Collared Investment Opportunity Etf Etf (ACIO)
Ishares Core S&p 500 Etf Etf (IVV)
Ishares Core Msci Eafe Etf Etf (IEFA)
Aptus Defined Risk Etf Etf (DRSK)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Aptus International Enhanced Yield Etf (IDUB)
Schwab U.s. Large-cap Growth Etf Etf (SCHG)
Opus Small Cap Value Etf Etf (OSCV)
Microsoft Corp Stock (MSFT)
Nvidia Corporation Stock (NVDA)
Ishares Core S&p Small Cap Etf Etf (IJR)
Apple Stock (AAPL)
Aptus Large Cap Enhanced Yield Etf Etf (DUBS)
Jpmorgan Hedged Equity Laddered Overlay Etf Etf (HELO)
Aptus Drawdown Managed Equity Etf Etf (ADME)

View all positions for Park Place Capital Corp

Top funds holding Agios Pharmaceuticals

BlackRock
Bellevue Group
T. Rowe Price Associates
Erste Asset Management GmbH
Jpmorgan Chase & Co
Dimensional Fund Advisors
Geode Capital Management
Marshall Wace
BVF
Frazier Life Sciences Management
Bnp Paribas Investment Partners
Arrowpoint Asset Management
Fisher Investments
Vestal Point Capital
Deutsche Bank Aktiengesellschaft

View all funds holding Agios Pharmaceuticals